insights+Analyses Published

We're attuned to (often ahead of) the key issues facing the market. It's about arming investors, consumers, and businesses with the information they need to make sound decisions.
Articles filtered by:

“Shall We Dance?”— Biologic-Biosimilar Competition Under the Biologics Price Competition and Innovation Act

As more biosimilar applications are filed, courts will inevitably face the novel and complex issues posed by the BPCIA with increasing frequency. I. ...

Monday, December 14, 2015

by Gregory Asciolla, Matthew Perez